Alzheimer’s drug rejected for widespread use by NHS spending watchdog
- Posted on October 23, 2024
- By Evening Standard
- 2 Views
Alzheimer’s drug rejected for widespread use by NHS spending watchdog
Donanemab is a so-called disease-modifying treatment.
